NCT05633004View on ClinicalTrials.gov

Avicena LVDP Validation Study

NACompletedINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

September 27, 2021

Primary Completion Date

September 8, 2022

Study Completion Date

September 30, 2022

Conditions
Heart Failure
Interventions
DEVICE

Vivio

Non-invasive estimation of Left-Ventricular End Diastolic Pressure (LVEDP)

Trial Locations (1)

49503

Spectrum, Grand Rapids

All Listed Sponsors
lead

Avicena LLC

INDUSTRY

NCT05633004 - Avicena LVDP Validation Study | Biotech Hunter | Biotech Hunter